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Abstract
Background: The specific palliative care needs and problems of patients with a substance use disorder and
multiple problems, and those of their proxies, are under recognized Besides, the organization of palliative care,
including the division of health care professionals’ responsibilities, is often unclear. Perspectives of patients and
proxies are hardly known. We describe the outline of a study designed to explore how palliative care for patients
with a substance use disorder is organized in the Netherlands and to explore problems and needs, as well as
possible improvements from the healthcare professionals’, patients’ and proxies’ perspective. The aim of this
protocol paper is to provide insights in ways to conduct research with vulnerable research participants and to offer
a detailed description of the study design. The broader study aims to gain insight in and formulate
recommendations on how to improve palliative care for patients with a substance use disorder.
Methods: A qualitative study with patients, proxies and healthcare professionals. Semi-structured interviews will be
held with 10–15 patients who suffer from a severe substance use disorder. They are in a palliative care trajectory
and either diagnosed with a chronic or life-threatening disease or, as a result of addictive behavior, a physical
deterioration without the prospect of cure. Semi-structured interviews will also be held with 5–10 proxies.
Healthcare professionals, volunteers and/or ‘experts-by-experience’ (n = 24–40) will be participating in semi-
structured group interviews. All (group) interviews will be thematically analyzed. Additionally, a strengths,
weaknesses, opportunities and threats (SWOT) analysis will be applied to the group interview data with the aim to
summarize and concretize the findings.
Discussion: Everyone has a right to an optimal end-of-life phase of life and a dignified dying process. This study will
provide valuable knowledge about palliative care for patients with a substance use disorder and explicitly bring to light
the needs and problems of the patients and their proxies and healthcare professionals in a palliative care phase.
Keywords: Qualitative research, Palliative care, Addiction, Substance use disorder, Vulnerability, Study protocol
Background
Although most people with a substance use disorder (SUD)
recover, others will be dependent during their entire life,
and thus are likely to die while still using substances [1, 2].
People with a SUD are likely to develop chronic or
life-threatening conditions and to die prematurely [3–10].
SUD is often chronic, albeit intermittent, and can have
far-reaching consequences on several life domains and
often results in problems like homelessness, financial issues,
loneliness or vulnerable social networks. Furthermore, it is
often accompanied by other psychiatric disorders [11–19].
SUD, thus, comes with multiple problems on patients’
physical, psychosocial and existential life domains.
For the reasons above, it is surprising that the litera-
ture about palliative care for patients with a SUD and
multiple problems (from now on to be referred to as
SUD+) is scarce. Palliative care has been defined as “an
approach that improves the quality of life of patients and
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their families facing the problem associated with
life-threatening illness, through the prevention and relief
of suffering by means of early identification and impec-
cable assessment and treatment of pain and other prob-
lems, physical, psychosocial and spiritual” [20]. The
scarce literature tends to focus on medical and clinical
issues, such as, pain assessment and management), inter-
action between addictive substances and medication, the
extent of alcoholism in the end-of-life phase and the ad-
dictive value of some medicines used in palliative care
(mainly opioids) [21–38].
Other literature, though, recognizes broad trends and
identifies various reasons that may jeopardize good pal-
liative care for patients with a SUD, such as
stigmatization; lack of training and education on this
subject; ineffectiveness of and tolerance for (pain) medi-
cation due to active substance use; risks of abuse of
medication by patients and; patients’ distrust,
non-compliance, symptom presentation and
non-disclosure of use [17, 39–46]. The current literature,
however, often consists of non-replicable literature re-
views or is more a reflection from the opinion of authors
and individual experts and based on case studies than
based on rigorous and valid research results. It fails to
grasp the actual care-experiences of patients, proxies
and healthcare professionals (HCPs). It often neglects
the multidimensional nature of palliative care and is
from American or Canadian origin; the findings cannot
always be extrapolated to West-Europe.
In view of the lack of evidence and expertise on pallia-
tive care for patients with a SUD, it may be worth investi-
gating the literature of an adjacent group, the homeless.
The two groups share a high premature mortality risk, se-
vere and persistent mental illness, chronic medical issues
and, social and financial issues [16, 47–54]. The literature
about palliative care for the homeless shows similar bar-
riers as the ones described above, but also shows that such
care is threatened by e.g. limited resources, little support
from proxies, no appropriate care site and coordination of
such care. Possible consequences are inappropriate pain
treatment and symptom management as well as delayed
recognition or anticipation of a patient’s deterioration or a
palliative care phase [55–57].
In brief: there is a great gap in our knowledge about
the specific needs and experiences of patients with a
SUD+ and their proxies in a palliative care phase. Fur-
thermore, the perspectives and needs of HCPs are also
little known. The research question addressed in this
study is therefore: “How is palliative care for patients
with a substance use disorder and multiple problems or-
ganized in the Netherlands, and what problems, needs,
improvements and good examples do healthcare profes-
sionals, patients and proxies experience or suggest?”.
Several subsidiary questions need to be answered:
a) How is palliative care for patients with a SUD+
organized in the Netherlands, both formally and in
daily practice?
b) What problems and needs in palliative care and
personal lives do patients with SUD+ and their
proxies’ experience?
c) What problems and needs do healthcare
professionals experience in providing palliative care
for patients with SUD+ and their proxies?
d) What are the positive experiences and best
practices in palliative care for patients with SUD+,
their proxies and health care professionals?
The objective of this study is to contribute to more co-
hesive and univocal care practice and policies for pa-
tients with SUD+ and their proxies and to formulate
recommendations for improvements. Additionally, the
study outcomes will serve as input for an education pro-
gram for Dutch HCPs. With this particular study proto-
col paper, we aim to provide a detailed description of the
study design and the methodological approach. By doing
so, we assure transparency and reproducibility. Also, we
give insight in ways to conduct research within a vulner-
able research population.
We provide the readers with a case study (Add-
itional file 1) to familiarize them with the uniqueness of
palliative care for patients with SUD+ with regard to, for
example, high pain medication and patients’ strong auton-
omy and limited communication about end-of-life issues.
Methods/Design
Study design
This exploratory study will use qualitative research method-
ologies. Individual, semi-structured interviews will be held
with patients and their proxies. HCPs, volunteers and
‘experts-by-experience’ will be participating in focus group
interviews. There will be no prior relationship between the
researchers and the participants. Topics of the interview
guides are based on the research questions, input and ex-
pertise of the project group (consisting of people with co-
ordination, research and clinical care experience in
addiction as well as in palliative care settings), and the lit-
erature. Data collection will take 5 months maximally. In-
terviews will be audio-recorded and transcribed verbatim.
To attain a complete overview of practice and experiences,
we strive to include participants from both metropolitan
areas and more rural areas. We will adhere to the COREQ
checklist (COnsolidated criteria for REporting Qualitative
research) for the scientific publications [58].
Inclusion and exclusion criteria
Patients and proxies
We aim to interview ten to fifteen patients with a SUD.
We believe that this number is enough for the exploratory
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goal of this study. However, if data saturation (reached
when no new data, themes and coding are emerging from
the interviews) will not be reached after this number of in-
terviews, more participants will be recruited [59]. Patients
will be identified and recruited by central HCPs: people
with key positions within the field of palliative care for pa-
tients with a SUD+. They mostly work in the fields of
SUD and/or psychiatry, but need to have some generic
knowledge about palliative care. They can be clinicians or
nurses and we expect that these HCPs encounter patients
with a SUD+ in a palliative care phase. Central HCPs will
be project group members or their colleagues or will be
recruited by the main researcher (AE).
Central HCPs will be asked to screen their patients on
the inclusion criteria and the information from an instruc-
tion brochure. If a patient is eligible, the central HCPs will
give him or her an information brochure and read this to-
gether. The central HCP is instructed to explicitly ask if
the information has been understood. If the patient agrees
to participate, the central HCP will inform the researcher,
who will, in turn, contact the patient by telephone to ar-
range inclusion. Inclusion is possible if the patient:
1) is either officially diagnosed with the DSM-V classi-
fication severe ‘substance use disorder’ or, if such a
diagnosis is lacking (e.g. caused by care-avoidance),
informally assessed as such by a central HCP expe-
rienced or educated in SUD, using the criteria of
the DSM-V (provided in the instruction brochure)
[11]. A patient could either be still an active user,
recently quit or in remission, of alcohol, cannabis,
cocaine, opioids (including heroin), sedatives (often
benzodiazepines) and/or Gamma-hydroxybutyric
acid (GHB);
2) has a serious non-reversible, life-threatening disease
(either as a consequence of a SUD or not, or is suf-
fering from progressive, severe physical deterior-
ation as a result of active addictive behavior which
will lead to death. Diagnosing a specific life-
threatening disease, such as cancer, is not always
the case;
3) is 18 years or older;
4) is sufficiently fluent in the Dutch language for the
purpose of an interview;
5) is cognitively capable enough to answer questions;
6) understands what participation in the study
involves: spending time and energy for the
interview and talking about a, potentially,
emotionally demanding subject.
Furthermore, the central HCP has to:
1) answer negatively to the ‘Surprise Question’:“would
it surprise you if this patient would die within the
next year?” Wishing to avoid selection bias through
including only patients in a terminal care phase, we
will explain to the central HCPs that this question
does not provide an estimate of life expectancy, but
serves to recognize and recruit patients with long-
term conditions such as cancer. They are not
necessarily expected to die within 12 months, but
this would not be a surprise either. They, however,
might benefit from palliative care services [60, 61].
2) state that he or she explicitly told the patient that
cure is no option and that a palliative phase has
been reached. It is obligatory that this information
should not have been told very recently. Also, the
patient needs to understand this information.
We believe that since central HCPs probably are close
to their patients and know them well and since patients
are conscious about being in a palliative care phase, pa-
tient drop-out or non-compliance for the interviews will
be low.
Exclusion criteria are the following. First, non-physical
addiction only, such as gambling, porn/sex or gaming,
will not be included, because these addictions do not
directly result in physical problems. Second, severe cog-
nitive impairment. Third, dependency on opioids for
medical reasons only.
We aim to include five to ten proxies; a limited num-
ber because people with a SUD tend to have few social
relations [17]. The researcher will ask participating pa-
tients to suggest a proxy, someone who is closest, albeit
after having checked with the central HCP whether in
individual cases there might be tensions or other sensi-
tivities which cannot be overcome. If a patient has sug-
gested a proxy, the researcher will ask the patient if the
proxy knows that the patient is in a palliative care phase.
If so, the researcher will send the proxy an information
brochure and contact him/her after a week for willing-
ness to participate.
Professional healthcare professionals, ‘experts-by-
experience’ and volunteers (HCPs+)
We aim to organize four focus groups, each consisting of
six to ten professional HCPs, ‘experts-by-experience’ and
volunteers (from now on to be referred to as HCPs+).
Experts-by-experience are people with lived experience of
SUD, however, they are in recovery. They use their former
experiences, e.g. in educating HCPs or supporting pa-
tients. We will be including different professions from dif-
ferent specializations and work sites to cover a wide range
of experiences. As the matrix shows (Table 1), we do not
aim to include people from specialized units in palliative
care or specialized addiction care only (Clusters A, B and
C). General care - often provided earlier during a care tra-
jectory - is equally important (Cluster D). With regard to
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setting or site, our strategy thus is purposive sampling: a
specific selection of research units, based on particular
characteristics [62]. We intend to compose one focus
group per cluster. Different recruiting strategies will be
used:
1) direct sampling: approaching familiar potential
participants directly from the project group
members’ networks;
2) respondent-driven sampling (a snowballing
method): asking potential participants whether they
know other potential participants [63] and;
3) broad to narrow sampling: asking registries and
(educational) institutions or organizations to
provide contact details of eligible HCPs+ or to pay
attention to the study on a website or in newsletters
or magazines. Also, we will post a call for
participation to LinkedIn.
All potential participants will receive an information
brochure, either directly (strategy 1) or after showing
interest (strategies 2 and 3). This brochure includes two
questions asking to self-report competencies in addiction
and palliative care. The HCPs+ will also be asked to pro-
vide some demographic details, so that the researchers
can assess whether enough diversity in the focus groups
has been reached. Demographic data will also provide
context for the interpretation of future results.
Data collection
Patients and proxies
AE will conduct semi-structured interviews with patients
and proxies, either at the place where the participant is
currently living, e.g.in a healthcare institution. An inter-
view is both a form of dialogue and bond between re-
searcher and participant. This qualitative method offers
room for the researcher to get to know the lives, worlds
and experiences of the participants. Participants in return
can fully express and explicate themselves as the interview
guide we developed, will not be strictly structured or stan-
dardized [62, 64]. Participants will be encouraged to speak
freely about emotions, thoughts, actions and experiences
with living with incurable disease, a SUD and the palliative
care they receive. The project group members in consult-
ation with an ‘expert-by-experience’ and a patient decided
it was best to draw up an interview guide using direct and
simple terminology and questions, especially in view of
the patients. In addition, the researcher will ask the central
HCP what end-of-life care terminology is best suited for
an individual patient, so as to increase recognition during
the interview.
Interviews with these vulnerable patients will be lim-
ited to 1 h, in line with the way patients often talk about
their lives: briefly and to the point. The proxy interviews
will be limited to one-and-a-half hour. However, inter-
views can be extended or, if necessary, continued at a
later date by mutual agreement between the participant
and the interviewer. Patient and proxy are both allowed
to bring somebody to the interview, if this makes them
feel more comfortable.
If possible, the researcher will request the patient’s
demographics from the central HCP before the sched-
uled date of the interview. This will allow reducing the
duration, and thus the burden of the interview and will
provide context to the results. Proxies will be asked to
provide a few demographics at the start of the interview.
Before starting of the interview, the interviewer will
briefly explain the rationale for this research as well as
the purpose of the interview. Only the interviewer’s
name, occupation and professional contact details will
be disclosed. Both patient and proxy will be, again, asked
to recount the patient’s illness trajectory. This will serve
to check whether they are aware that the patient is in
the palliative care phase. If this does not appear to be
the case, the interviewer needs to be flexible and adapt
the interview to the patient’s current health situation.
During an interview, the interviewer will write down
keywords on cards so as to be able to provide feedback
on the interviewee’s information provision. If necessary,
the interviewer will also write field notes to be able to
probe more efficiently. Furthermore, the interviewer will
bring so-called association cards that contain pictures
which can be used as metaphors when a participant is
struggling to find the right words for experiences [65].
These will be used only as a back-up method for data
collection.
The main- and subtopics addressed in the interview
guide for patients and proxies are presented in Table 2.
These are the areas around which the open-ended ques-
tions were developed. Subtopics are provided because
Table 1 Sites of ‘experts-by-experience’
Specialized palliative care settings Settings with a generic palliative
care approach (not-specialized)
Specialized SUD or psychiatry (treatment) settings Cluster A
e.g. a nursing home or hospice
for people with addiction
Cluster B
e.g. an addiction and/or mental health institute
Settings with a generic approach to SUD or
psychiatry (not-specialized)
Cluster C
e.g. a palliative consult team
Cluster D
e.g. a general practitioner service or hospital
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the project group members know from experience that
this patient group, in general, is not very talkative.
Healthcare professionals, ‘experts-by-experience’ and
volunteers
Focus group interviews will be led by MG and AE at cen-
trally situated venues in the Netherlands. This method is
suitable for grasping a diversity of opinions and experi-
ences [66] and collecting a large amount of data in a short
time. The group interviews will take approximately 2 h. A
semi-structured interview guide will be used [62, 64].
Main topics of the guide are: 1) Content of care on the
palliative care dimensions (physical, psychosocial and spir-
itual, and pain) and existential issues; 2) Organization of
palliative care for patients with SUD+; 3) Communication
with patients; 4) Care for proxies and; 5) Knowledge and
competence, relating to palliative care and SUD+. These
are the areas around which the researchers developed
open-ended questions. Subtopics are not provided. Issues
that are important to HCPs+ are expected to emerge from
the discussions and the open-ended and follow-up ques-
tions. Each main theme, however, was provided with con-
tributive examples, serving as basis for potential probing
questions in case nothing came up during the interviews,
e.g. cooperation or identification of palliative care phase
for the theme ‘organization of palliative care for patients
with SUD+’.
The focus group sessions will be concluded with what is
known as a strengths, weaknesses, opportunities and
threats (SWOT) analysis. This analysis is suitable for deliv-
ering practical and clear results. Strengths and weaknesses
refer to the internal environment of HCPs+’ workplace.
These are either positive or negative attributes that stimu-
late or hinder the development of palliative care for patients
with a SUD, e.g. personnel or location. Opportunities and
threats are positive or negative conditions outside the work-
place that stimulate or hinder the development of palliative
care for patients with a SUD, e.g. stigmatization or political
environment [67–69]. The workings of the SWOT analysis
will be explained, after which the HCPs+ will be invited to
state what SWOT-elements of current palliative care for
patients with a SUD+ they find most important with regard
to the five main interview topics. Participants will be given
sticky notes on which they can write down these elements
and which they can stick to five posters. We purposively
have chosen for a combination of both a group interview
and a concluding SWOT analysis, as the latter will serve as
a summary of what has been discussed and a prioritization
of the most important findings.
Data analysis
Patients and proxies
Researchers (AE and MG) will use a two-stepped thematic
content analysis, consisting of a directed and a conven-
tional approach [70]. In the first step, coding is quite di-
rected and deductive: main themes or main codes -
derived from the research questions - will be linked to the
relevant parts of the first interview transcripts, until inter
coder reliability is reached [71]. This is an initial step in
organizing the data. These main themes are: needs in per-
sonal lives, healthcare needs, healthcare problems, positive
experiences within care and healthcare improvements.
The second step consists of applying so-called ‘baby–
codes’ within the main themes of the first interviews.
These codes will be applied to words or text segments that
capture concepts or thoughts relevant to the research
questions. By staying as close as possible to the original
data, we will create inductive codes that contain experi-
ences from the participants’ perspectives. This is a way of
avoiding over interpretation by the researcher. Afterwards,
these ‘baby-codes’ are clustered into categories or sub-
themes, based on how the ‘baby-codes’ are related with
each other and a particular main theme (axial coding).
Each subtheme then is provided with a description. In this
way, a codebook is created which will serve as a coding
strategy for the analysis of the remaining interviews. The
analysis process will be iterative: while analyzing, codes
and relations between them can be continuously and re-
peatedly updated or adapted with new data (collected by
the interviews) and critical and reflective questions that
arise while analyzing [70, 72, 73].
After data analysis, the main researcher will present
the findings to a similar patient group: residents of a Sal-
vation Army nursing home specialized in complex care
and treatment. These residents are in a better health
state, but will meet many of the inclusion criteria applied
Table 2 Main and sub-topics of patient and proxy* interviews
Main topics Subtopics
1. Healthcare Care network, organization of care, attention for different dimensions,
HCPs’ coping with a SUD, communication with HCPs
2. Physical health Pain (control), symptom (burden), impact of a SUD
3. Social aspects Social network / isolation, communication with others, impact of a SUD
4. Psychological and existential issues Life values, sources of strength, future, place of death, impact of a SUD
5. Proxy experiences Contact between HCPs and proxy, care for proxy, involvement in
planning and decision-making and, needs in life and care.
*Proxies will be asked questions from domains 1 to 4 relating to the patient’s situation
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to the study group. As a surrogate “member check”, they
will be asked to what extent they recognize themselves
in the results of the whole study group. The purpose of
this surrogate “member check” is thus to more or less
validate the study results [74]. The project group choose
this surrogate “member check” instead of asking the par-
ticipating patients from the original interviews, for a
member check, because from practical and clinical ex-
perience it appeared it would be too burdensome to ask
patients twice. Also, participating twice could withhold
patients from participation at all.
Healthcare professionals, ‘experts-by-experience’ and
volunteers
The interview transcripts of the focus groups will be an-
alyzed in a similar way as the patient and proxy inter-
views. The main and subthemes, however, will be
different and constitute the fives topics used in the focus
group interviews. Again, a codebook will be created [70].
Afterwards, a matrix will be constructed per main
theme, including the SWOT-elements mentioned.
Regarding the patient, proxy and focus group inter-
views, two researchers (AE and MG) will analyze the
data until consensus about the codebooks can be estab-
lished. Then, AE alone will continue the coding process.
In this way interpretation and researcher bias is mini-
mized and validity is strived for. Still, AE and MG will
frequently join each other for discussions relevant to the
analysis process. Data analysis is computer-aided by the
qualitative research software Atlas.ti version 7.
Ethical considerations
Eligible participants will receive an information brochure
containing the study’s goal, content, details of participa-
tion and mentioning that they can withdraw from the
study at any time. They will be given the opportunity to
put questions to the researcher and are given a mini-
mum of a week to decide about participation. In case
they have not responded within this week, AE will con-
tact them. Before the interview starts, informed consent
will be signed by the participant and researcher. The
participant thereby states to: 1) agree that the interview
will be audio-recorded; 2) understand the information
provided; and 3) participate voluntarily. Participants, will
receive a small gift at the end of the interview.
Participants’ names and demographics and interview
data will be stored in encrypted databases. Participants’
names and other details will be assigned a code in a
computer file, which is protected by a password only
known by the researchers. In future publications, inter-
view transcripts and the “member check”, only these
codes will be used to guarantee participants’ anonymity
and privacy. Patients and proxies will be invited to re-
ceive a transcript of their interview.
The risk of taking part in this study was categorized as
‘negligible’ [75]. Still, several steps have been undertaken
to minimize the burden for the patients especially. First,
an ‘expert-by-experience’ and patient with a SUD+ have
helped drawing up the study protocol, the interview
guides, recruitment and inclusion strategy, and informa-
tion brochures. Their ideas about burden, structure,
themes, terminology and understandability of the inter-
view questions and information brochure were taken
seriously. Second, interviews will be restricted in dur-
ation and will be held only once. Furthermore, the inter-
viewer will ask the patients and proxies repeatedly
whether they are still willing and able to continue. Third,
participants can end participation at any time, without
being obliged to give a reason. Fourth, the researchers
are trained and experienced in communicating with vul-
nerable patient groups. Additionally, if the interviewer
notices that a patient or proxy is struggling emotionally,
she will tell so and discuss with the participant whether
or not to continue the interview. Participants who are
sad, anxious or show other negative emotions after the
interview will be recommended to contact their own so-
cial or medical network or to find support from the per-
son, if any, they brought to the interview. If there is no
such network, the interviewer could potentially inter-
vene by proposing to call the participant’s general practi-
tioner. Lastly, the surrogate “member check” in which
the researcher will present her findings during a monthly
meeting for residents of the Salvation Army care home.
These residents join voluntarily.
Although speculating about long-term consequences
might be challenging, we believe that the psychological
risks of participating in this study are minimal. Participa-
tion might even be experienced as beneficial and positive.
Patients in a palliative care phase may find it therapeutic
to share their problems or to contribute to research and
thereby support other patients. Also, studies have shown
that patients and their proxies find talking about death
and dying (timely) helpful in getting a better grip on the
situation [76, 77] and could bring rest, connection, an
actualization of wishes and less anxiety [78]. For health-
care professionals, volunteers and ‘experts-by-experience’,
study participation can be beneficial because they contrib-
ute to the advancement of palliative care for a vulnerable
patient group. Also, they will reflect on and be inspired by
a comparison of their own experiences, practices and col-
laboration and those of other HCPs+.
Discussion
Strengths
The network of the project group is diverse and will be
of great help in recruiting patients as well as HCPs+
from Clusters A, B and C (see Table 1). Furthermore,
this project allows to combine empirical results from
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different points of views of people involved with pallia-
tive care for patients with a substance use disorder and
multiple problems. Finally, the study will grasp the
multidimensional aspects of healthcare and care
experiences.
Challenges
Recruitment of patients probably will be hard because
they often do not show up for appointments and might
not be tempted to talk (extensively) about issues that
might trigger emotions, e.g. shame [39, 41–43, 79]. It is
likely that HCPs+ from Cluster D will be harder to re-
cruit, as patients with SUD are not always visible and ex-
periences with this patient group might be rare. Also,
recruiting proxies might be a challenge as the social net-
works of patients are often limited.
Conclusion
This study protocol article provides insights into ways to
conduct research with vulnerable research participants, by
offering a detailed description of the study design and the
methodological approaches. The outcomes will include an
explicit recognition of problems, needs, good examples and
improvements experienced or suggested by patients with a
SUD+, proxies, healthcare professionals, volunteers and
‘experts-by-experience’. The study will provide valuable
knowledge on how to improve clinical practice, and patient
and proxy care. Additionally, the findings will lie at the
foundation for an education program for Dutch HCPs who
are dealing with patients with SUD+ in a palliative care
phase. In the end, this project aims to achieve an optimal
end-of-life phase and a dignified dying process for patients
with a substance use disorder and multiple problems.
Additional file
Additional file 1: Case Study SUD+. (DOC 27 kb)
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